Healthcare · NIFTY 500
Vijaya Diagnostic Centre Limited
NSEVIJAYA
BSE543350 ISININE043W01024 SeriesEQ Listed on NSE · BSE
₹1,415.60 -8.20 (-0.58%) Updated 12 Nov, 8:49 pm IST
Price, daily close+43.24% in a year
Today
- Open
- ₹1,423.30
- Prev close
- ₹1,423.80
- Day high
- ₹1,438.00
- Day low
- ₹1,407.40
- Volume
- 1.54 L
- Value traded
- ₹21.84 Cr
- Upper circuit
- ₹1,708.50
- Lower circuit
- ₹1,139.10
- 52W high
- ₹1,593.60
- 52W low
- ₹848.00
- 1 month
- +2.62%
- 6 months
- +9.38%
52W low52W high
Ratios
Key numbers
Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.
Market cap₹14,580 Cr
P/E (TTM)71.68
P/B13.79
Book value / share₹102.66
EPS (TTM)₹19.75
ROE19.3%
Dividend yield0.14%
Dividend (12m)₹2.00 / share
Net margin (TTM)22.4%
Operating margin44.1%
Debt / equity—
Current ratio2.80
EV / EBITDA37.09
Sales growth (YoY qtr)+26.70%
Profit growth (YoY qtr)+37.41%
Sales CAGR 3Y+21.03%
Profit CAGR 3Y+26.91%
Shares10.30 Cr
Quarterly results
Results for each quarter
Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.
Revenue and net profit
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Revenue · QoQ (vs last quarter)
—+17%+0.7%+17%-7.6%+2.5%+8.5%+7.2%+1.8%+6.9%+5.3%+11%
Revenue · YoY (vs a year ago)
————+27%+12%+20%+10%+21%+27%+23%+27%
Net profit · QoQ (vs last quarter)
—+29%-6.3%+34%-16%-1.5%+11%+13%-0.2%+11%+11%+12%
Net profit · YoY (vs a year ago)
————+36%+3.5%+22%+3.2%+23%+38%+39%+37%
RevenueNet profitLine = trend
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
EPS (₹) · YoY (vs a year ago)
————+36%+3.4%+23%+2.9%+23%+38%+37%+37%
EPS (₹)Line = trend
| ₹ Cr | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 133 | 155 | 156 | 183 | 169 | 173 | 188 | 202 | 205 | 219 | 231 | 255 |
| Other income | 5.1 | 3.3 | 3.6 | 4.5 | 4.7 | 5.5 | 7.0 | 6.2 | 5.1 | 2.4 | 8.5 | 5.0 |
| Total income | 138 | 158 | 160 | 187 | 174 | 179 | 195 | 208 | 210 | 222 | 240 | 260 |
| Raw material | 16.0 | 18.8 | 18.8 | 23.0 | 20.9 | 22.2 | 21.4 | 24.3 | 24.0 | 24.9 | 25.6 | 28.3 |
| Purchases | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Employee cost | 23.0 | 24.5 | 27.4 | 27.8 | 28.6 | 28.4 | 31.6 | 32.3 | 33.0 | 33.8 | 37.5 | 38.3 |
| Other expenses | 41.4 | 48.8 | 48.9 | 56.1 | 52.4 | 53.8 | 61.5 | 63.2 | 62.1 | 65.1 | 69.4 | 76.0 |
| Total expenses | 101 | 115 | 118 | 130 | 127 | 130 | 143 | 150 | 152 | 158 | 169 | 181 |
| Operating profit | 50.3 | 63.1 | 61.2 | 76.0 | 67.1 | 67.8 | 73.5 | 81.8 | 86.1 | 95.5 | 98.5 | 113 |
| OPM % | 37.9% | 40.7% | 39.2% | 41.5% | 39.7% | 39.2% | 39.1% | 40.6% | 41.9% | 43.5% | 42.7% | 44.1% |
| Finance cost | 6.1 | 6.2 | 6.3 | 6.5 | 6.8 | 7.2 | 7.5 | 7.8 | 8.6 | 9.3 | 11.0 | 11.4 |
| Depreciation | 14.5 | 16.3 | 16.6 | 16.8 | 18.3 | 18.8 | 20.9 | 22.3 | 24.3 | 24.3 | 25.1 | 26.9 |
| Exceptional items | -2.1 | — | — | — | — | -1.0 | — | — | — | — | — | — |
| Profit before tax | 34.8 | 43.9 | 41.9 | 57.2 | 46.7 | 47.4 | 52.2 | 58.0 | 58.2 | 64.3 | 70.9 | 79.4 |
| Tax | 8.8 | 10.2 | 10.4 | 15.1 | 11.4 | 12.5 | 13.6 | 14.7 | 15.0 | 16.3 | 17.8 | 19.9 |
| Net profit | 26.0 | 33.7 | 31.5 | 42.1 | 35.3 | 34.9 | 38.6 | 43.3 | 43.2 | 47.9 | 53.1 | 59.5 |
| Profit to shareholders | 25.8 | 33.5 | 31.3 | 41.9 | 35.2 | 34.6 | 38.3 | 43.3 | 43.2 | 47.9 | 53.1 | 59.5 |
| EPS (₹) | 2.52 | 3.26 | 3.05 | 4.08 | 3.42 | 3.37 | 3.75 | 4.20 | 4.19 | 4.65 | 5.15 | 5.76 |
Profit & loss
Results for each year
5 financial years (April to March), consolidated, ₹ crore.
Sales, operating profit and net profit
FY22
FY23
FY24
FY25
FY26
Revenue · YoY (vs a year ago)
—-0.7%+19%+24%+19%
Net profit · YoY (vs a year ago)
—-23%+40%+20%+21%
RevenueOperating profitNet profitLine = trend
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 462 | 459 | 548 | 681 | 814 |
| Other income | 12.8 | 14.2 | 20.8 | 18.3 | 20.8 |
| Total expenses | 328 | 360 | 408 | 506 | 602 |
| Employee cost | 70.7 | 78.5 | 90.2 | 112 | 131 |
| Operating profit | 204 | 182 | 219 | 272 | 337 |
| OPM % | 44.1% | 39.6% | 40.0% | 39.9% | 41.4% |
| Finance cost | 16.5 | 20.9 | 24.0 | 26.7 | 33.2 |
| Depreciation | 52.7 | 61.7 | 57.0 | 70.6 | 91.8 |
| Profit before tax | 147 | 114 | 159 | 193 | 233 |
| Tax | 36.7 | 28.3 | 39.0 | 49.4 | 59.7 |
| Tax rate % | 24.9% | 24.9% | 24.6% | 25.6% | 25.7% |
| Net profit | 111 | 85.2 | 120 | 144 | 173 |
| Profit to shareholders | 110 | 84.6 | 119 | 143 | 173 |
| Net margin % | 23.7% | 18.4% | 21.7% | 21.0% | 21.2% |
| EPS (₹) | 10.69 | 8.26 | 11.59 | 13.92 | 16.79 |
Balance sheet
Assets and debt
At each year end (and the latest half year), ₹ crore.
Equity, debt and assets
Mar 23
Mar 24
Mar 25
Mar 26
Sep 26
Shareholders' equity · YoY (vs a year ago)
—+21%+21%+20%—
Shareholders' equityBorrowingsCashLine = trend
| ₹ Cr | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Sep 26 |
|---|---|---|---|---|---|
| Shareholders' equity | 545 | 657 | 796 | 957 | 1,057 |
| Long-term borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Short-term borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current liabilities | 66.2 | 72.9 | 163 | 124 | 161 |
| Fixed assets (PPE) | 294 | 602 | 724 | 930 | 1,045 |
| Inventories | 2.0 | 5.2 | 4.9 | 4.9 | 8.3 |
| Trade receivables | 9.5 | 16.2 | 14.8 | 20.9 | 17.9 |
| Cash & equivalents | 24.2 | 22.2 | 12.8 | 39.7 | 10.1 |
| Current assets | 276 | 211 | 307 | 322 | 450 |
| Total assets | 853 | 983 | 1,274 | 1,507 | 1,733 |
Cash flow
Cash coming in and going out
For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.
Operating, investing and financing cash
FY22
FY23
FY24
FY25
FY26
Operations · YoY (vs a year ago)
—+4.2%+11%+22%+21%
OperationsInvestingFinancingLine = trend
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 158 | 165 | 183 | 224 | 271 |
| Cash from investing | -123 | -110 | -142 | -182 | -174 |
| Cash from financing | -30.6 | -41.9 | -44.5 | -52.0 | -69.5 |
| Spent on fixed assets | -122 | -125 | -88.0 | -95.6 | -183 |
| Free cash flow | 35.7 | 39.8 | 95.3 | 129 | 87.9 |
| Net cash flow | 4.4 | 13.1 | -3.6 | -9.4 | 26.9 |
Shareholding
Who holds the shares
Promoter and public holding at each quarter end, as filed with NSE.
Holding over time
Promoter & groupPublic
Latest (30 Sep 2026)
52.5%promoter
- Promoter & group
- 52.46%
- Public (FIIs, mutual funds, retail…)
- 47.54%
- Promoter change, last quarter
- -0.05 pts
Dividends & news
Latest dividends and announcements
Dividends & corporate actions
- Dividend - Rs 2 Per Share
- Dividend - Rs 2 Per Share
- Dividend - Re 1 Per Share
- Annual General Meeting/Dividend - Re 1 Per Share
- Dividend - Re 1 Per Share
Board meetings
- Vijaya Diagnostic Centre Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaud…
- the financial results for the Quarter and Half year ended September 30, 2026
- the financial results for the period ended Jun 30, 2026 and other business matters
- the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Other business.
- the financial results for the period ended March 31, 2026, dividend and other business matters
Filings with NSE
- Analysts/Institutional Investor Meet/Con. Call Updates
- Copy of Newspaper Publication
- Analysts/Institutional Investor Meet/Con. Call Updates
- Investor Presentation
- Press Release
- Appointment
- Outcome of Board Meeting
Latest news
VIJAYA Forecast — Price Target — Prediction for 2027TradingView · 25 Jun, 7:31 pmBuy Vijaya Diagnostic Centre; target of Rs 1600: ICICI SecuritiesMoneycontrol.com · 12 Aug, 12:30 pmVijaya Diagnostic Centre Share Price Target 2027: 17.7% UpsideUnivest · 6 Nov, 1:22 pmVijaya Diagnostic Centre Limited Just Recorded A 10% EPS Beat: Here's What Analysts Are Forecasting NextSimply Wall St · 6 Nov, 5:48 amVijaya Diagnostic Centre Reports Q1 Net Profit of 531m Rupees on Revenue of 2.31bSahi · 7 Aug, 12:30 pmVijaya Diagnostic Centre Announces Key Leadership Appointments and Board Changesscanx.trade · 13 Feb, 1:30 pmPrice Action: Global Health up 6%, Vijaya Diagnostic down 3% post Q2 earningsMoneycontrol.com · 4 Nov, 1:30 pmVijaya Diagnostic Centre Share Price Falling Today: Stock Drops 5.11% to Rs 1,340.30 on 17 July 2026Univest · 17 Jul, 12:30 pmAbout
About Vijaya Diagnostic Centre Limited
Vijaya Diagnostic Centre Limited is listed on the NSE under the symbol VIJAYA and belongs to the Healthcare sector.
Company details
- Company name
- Vijaya Diagnostic Centre Limited
- NSE symbol
- VIJAYA
- BSE scrip code
- 543350
- ISIN
- INE043W01024
- Listed on
- NSE, BSE
- Series
- EQ (normal equity)
- Listed on NSE since
- 14 Sep 2021
- Face value
- ₹1 per share
- Market lot
- 1 share
- Shares issued
- 10.30 crore
- Index
- NIFTY 500
- Sector (NSE)
- Healthcare
- Industry
- Medical/Nursing Services
- Managing director / CEO
- Sura Suprita Reddy
- Chair
- Sura Surendranath Reddy
- Headquarters
- Hyderabad, Telangana, India
- Registered address
- 6-3-883/F, Ground Floor, FPA Building, Near Topaz Building, Punjagutta, Hyderabad 500082, Telangana
- Founded
- 2002
- Employees
- 2,507
- Financial year
- April to March
- Results basis
- Consolidated
- Website
- vijayadiagnostic.com
Peers
Other Healthcare stocks
-
DIVISLABDivi's Laboratories
₹11,485.00
+1.04%
-
ALKEMAlkem Laboratories
₹5,302.00
-2.68%
-
GRANULESGranules India
₹840.50
+5.16%
-
SUNPHARMASun Pharmaceutical Industries
₹1,885.00
-0.91%
-
LAURUSLABSLaurus Labs
₹2,400.00
-1.19%
-
AUROPHARMAAurobindo Pharma
₹1,807.20
-1.11%
-
ACUTAASAcutaas Chemicals
₹3,996.10
+2.02%
-
APOLLOHOSPApollo Hospitals Enterprise
₹8,515.00
-1.03%
Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.